Why Scantox as your preferred CRO?
Our services support a broad spectrum of preclinical drug development elements. From lead optimization within in vitro and in vivo efficacy models, formulation development, regulatory toxicology studies incl. supportive functions as clinical pathology, bioanalysis, histology all the way to manufacturing and distribution of products for clinical trial phase 1 and 2.
Business Units
With a broad and integrated service portfolio spanning Discovery, Regulatory Toxicology, and Analytical Services, we serve as a trusted partner to clients worldwide. Our vision is to deliver a seamless experience across all our sites, built on direct scientist-to-scientist collaboration.
Discovery Services
Scantox offers specialized discovery services that cater to the advancement of neurology-related pharmaceutical research and development. At Scantox Neuro, the focus is on providing comprehensive solutions that support the early stages of drug discovery, particularly in the context of neurological diseases. The services include a range of preclinical studies designed to evaluate the efficacy and safety of potential neurotherapeutic agents.
Genetic Toxicology Services
Scantox offers a comprehensive portfolio of screening and regulatory genotoxicity products & services, along with assessment of skin sensitisation potential.
Regulatory Toxicology Services
Regulatory toxicology is one of our core competences, and Scantox has for many years been a leading expert within safety studies using the Göttingen Minipig. We offer a full spectrum of preclinical toxicology studies, incl. GLP, and a wide species selection.
Pharmaceutical Devevelopment & Analytical Services
We offer formulation development and dose formulation manufactory including logistics for phase 1 and 2 clinical trials. Further, a full spectrum of bioanalysis with a comprehensive full package of LCMC/MS method development, validation and sample analysis for both for exploratory, regulatory studies and clinical.
NEWS
JOIN
our next webinar
The Scantox webinars are free to attend, and a great opportunity to gain scientific insights from our subject matter experts.
Addressing Genetic Toxicology Assessments Across Screening, Regulatory Stages, and Beyond
Date: December 10, 2025
Time: 15:00 CET | 9:00 AM EST
Watch webinars on-demand
Most Recent Scientific Publications
In Focus
Sustainability is built into how Scantox operates – from how we source energy and manage facilities to how we train, report, and collaborate. Our approach balances scientific rigor with ethical responsibility, offering measurable impact to the clients we serve.
Shape the Future with Scantox
At Scantox, your background doesn’t define your future. We offer meaningful projects, real impact, and space to grow wherever you start.
We’re looking for empathetic, passionate people who take initiative, embrace challenges, and aim to make a difference.
Join Scantox Group and help shape the future for patients worldwide.